Literature DB >> 30717902

Management of Papillary Thyroid Microcarcinoma.

Juan P Brito1, Ian D Hay2.   

Abstract

The worldwide incidence of thyroid cancer is increasing. A third of new thyroid cancer cases are papillary thyroid microcarcinoma (PTM), which are 1 cm or less. These tumors are mostly indolent with excellent prognosis. Although thyroid surgery is the most common management option for patients with PTM, new management options demand that treatment decisions must be individualized and based on patient's preference, context, and biology. This article describes management options for PTM patients and shared decision-making as a novel method for individualizing care.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Management; Microcarcinoma; Papillary thyroid cancer; Shared decision-making

Mesh:

Year:  2018        PMID: 30717902     DOI: 10.1016/j.ecl.2018.10.006

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  15 in total

1.  Machine Learning-Based Shear Wave Elastography Elastic Index (SWEEI) in Predicting Cervical Lymph Node Metastasis of Papillary Thyroid Microcarcinoma: A Comparative Analysis of Five Practical Prediction Models.

Authors:  Xue Huang; Yukun Zhang; Du He; Lin Lai; Jun Chen; Tao Zhang; Huilin Mao
Journal:  Cancer Manag Res       Date:  2022-09-21       Impact factor: 3.602

2.  Long-Term Results of Treating With Ethanol Ablation 15 Adult Patients With cT1aN0 Papillary Thyroid Microcarcinoma.

Authors:  Ian D Hay; Robert A Lee; Suneetha Kaggal; John C Morris; Marius N Stan; M Regina Castro; Vahab Fatourechi; Geoffrey B Thompson; J William Charboneau; Carl C Reading
Journal:  J Endocr Soc       Date:  2020-09-15

3.  Impact of prophylactic unilateral central neck dissection needed for patients with papillary thyroid microcarcinoma.

Authors:  Young Jae Ryu; Jung Han Yoon
Journal:  Gland Surg       Date:  2020-04

4.  Fine Needle Biopsy Versus Core Needle Biopsy Combined With/Without Thyroglobulin or BRAF 600E Mutation Assessment for Detecting Cervical Nodal Metastasis of Papillary Thyroid Carcinoma.

Authors:  Xiaojun Zhang; Xu Zhang; Wei Du; Liyuan Dai; Ruihua Luo; Qigen Fang; Hong Ge
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-12       Impact factor: 5.555

5.  Deltex3 inhibits Epithelial Mesenchymal Transition in Papillary Thyroid Carcinoma via promoting ubiquitination of XRCC5 to regulate the AKT signal pathway.

Authors:  Lidong Wang; Yonglian Huang; Chenxi Liu; Mingyue Guo; Zhennan Ma; Jingni He; Ailian Wang; Xiaodan Sun; Zhen Liu
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

6.  Identification of DNA Repair-Related Genes Predicting Clinical Outcome for Thyroid Cancer.

Authors:  Ai-Ying Zhang; Wei Li; Hai-Yan Zhou; Jing Chen; Li-Bin Zhang
Journal:  J Oncol       Date:  2022-01-06       Impact factor: 4.375

7.  Clinicopathological Findings Associated With Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study in China.

Authors:  Yimeng Shi; Zheyu Yang; Yu Heng; Huijun Ju; Yu Pan; Yifan Zhang
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

8.  TERT Promoter Mutations Are an Independent Predictor of Distant Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma.

Authors:  Sandeep Kumar Parvathareddy; Abdul K Siraj; Kaleem Iqbal; Zeeshan Qadri; Saeeda O Ahmed; Maha Al-Rasheed; Ahmed A AlQatie; Saif S Al-Sobhi; Fouad Al-Dayel; Khawla S Al-Kuraya
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-11       Impact factor: 5.555

9.  Predicting factors of central lymph node metastasis and BRAFV600E mutation in Chinese population with papillary thyroid carcinoma.

Authors:  Sheng Li Zhou; Yan Ping Guo; Lei Zhang; Tao Deng; Zi Guang Xu; Chao Ding; Wen Cong Sun; Yue Wu Zhao; Ling Fei Kong
Journal:  World J Surg Oncol       Date:  2021-07-13       Impact factor: 2.754

10.  Diagnostic Efficacy of Ultrasound, Cytology, and BRAFV600E Mutation Analysis and Their Combined Use in Thyroid Nodule Screening for Papillary Thyroid Microcarcinoma.

Authors:  Jing Du; Ruijun Han; Cui Chen; Xiaowei Ma; Yuling Shen; Jun Chen; Fenghua Li
Journal:  Front Oncol       Date:  2022-01-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.